Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses

Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype. Non-available targeted therapy for TNBC represents its biggest treatment challenge. Thus, finding new promising effective drugs is urgently needed. In the present study, we investigated how berberine, a natural isoquinoline...

Descripción completa

Detalles Bibliográficos
Autores principales: El Khalki, Lamyae, Maire, Virginie, Dubois, Thierry, Zyad, Abdelmajid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036777/
https://www.ncbi.nlm.nih.gov/pubmed/31991634
http://dx.doi.org/10.3390/molecules25030506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036777/
https://www.ncbi.nlm.nih.gov/pubmed/31991634
http://dx.doi.org/10.3390/molecules25030506

Ejemplares similares